Egle Therapeutics
Entity

  • Egle Therapeutics

    Created in 2020


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    3,687

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    75013 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 43

  • Engaged catalyst

    3
    0 0

  • Added in Motherbase

    1 year, 9 months ago
Description
  • Value proposition

    Modulating T-regulatory cells to balance immunity

    Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.

  • Egle Therapeutics

    Egle therapeutics is a clinical stage company developing innovative therapies for those battling cancer and autoimmune diseases. Fueled by scientific advances in the understanding of the role of regulatory T cells (Treg), our therapies uniquely focus on their modulation in disease tissues.

    • https://www.egle-tx.com/
Catalyst interactions
Catalyst TypeTweets Articles
Takeda
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Takeda
Pharmaceutical, Pharmaceutical Manufacturing 		Other

20 Mar 2025


Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care 		Other

20 Mar 2025


Paris Biotech Santé
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations 		Other

6 Oct 2022


Social network dynamics
Similar entities
BETA
Last news
Show all articles